Genetic Polymorphisms and Sepsis in Premature Neonates

Identifying single nucleotide polymorphisms (SNPs) in the genes involved in sepsis may help to clarify the pathophysiology of neonatal sepsis. The aim of this study was to evaluate the relationships between sepsis in pre-term neonates and genes potentially involved in the response to invasion by infectious agents. The study involved 101 pre-term neonates born between June 2008 and May 2012 with a diagnosis of microbiologically confirmed sepsis, 98 pre-term neonates with clinical sepsis and 100 randomly selected, otherwise healthy pre-term neonates born during the study period. During the study, 47 SNPs in 18 candidate genes were genotyped on Guthrie cards using an ABI PRISM 7900 HT Fast real-time and MAssARRAY for nucleic acids instruments. Genotypes CT and TT of rs1143643 (the IL1β gene) and genotype GG of rs2664349GG (the MMP-16 gene) were associated with a significantly increased overall risk of developing sepsis (p = 0.03, p = 0.05 and p = 0.03), whereas genotypes AG of rs4358188 (the BPI gene) and CT of rs1799946 (the DEFβ1 gene) were associated with a significantly reduced risk of developing sepsis (p = 0.05 for both). Among the patients with bacteriologically confirmed sepsis, only genotype GG of rs2664349 (the MMP-16 gene) showed a significant association with an increased risk (p = 0.02). Genotypes GG of rs2569190 (the CD14 gene) and AT of rs4073 (the IL8 gene) were associated with a significantly increased risk of developing severe sepsis (p = 0.05 and p = 0.01). Genotype AG of rs1800629 (the LTA gene) and genotypes CC and CT of rs1341023 (the BPI gene) were associated with a significantly increased risk of developing Gram-negative sepsis (p = 0.04, p = 0.04 and p = 0.03). These results show that genetic variability seems to play a role in sepsis in pre-term neonates by influencing susceptibility to and the severity of the disease, as well as the risk of having disease due to specific pathogens.

[1]  H. Repo,et al.  Extracellular Release of Bactericidal/Permeability-Increasing Protein in Newborn Infants , 2002, Pediatric Research.

[2]  G. Waterer,et al.  Genetic predisposition to respiratory infection and sepsis , 2011, Critical reviews in clinical laboratory sciences.

[3]  Thomas P. Shanley,et al.  Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum* , 2009, Critical care medicine.

[4]  R. Khokha,et al.  Metalloproteinases and their natural inhibitors in inflammation and immunity , 2013, Nature Reviews Immunology.

[5]  J. Mejía-Aranguré,et al.  Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case–control study , 2012, BMC Infectious Diseases.

[6]  Dechang Chen,et al.  Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients* , 2002, Critical care medicine.

[7]  C. Delacourt,et al.  Matrix Metalloproteinase Gene Polymorphisms and Bronchopulmonary Dysplasia: Identification of MMP16 as a New Player in Lung Development , 2008, PloS one.

[8]  A. Hoeft,et al.  PROTECTION AGAINST PSEUDOMONAS AERUGINOSA PNEUMONIA AND SEPSIS-INDUCED LUNG INJURY BY OVEREXPRESSION of &bgr;-DEFENSIN-2 IN RATS , 2006, Shock.

[9]  J. Michálek,et al.  Bactericidal permeability increasing protein gene variants in children with sepsis , 2007, Intensive Care Medicine.

[10]  A. Telenti,et al.  Innate immunogenetics: a tool for exploring new frontiers of host defence , 2007, The Lancet Infectious Diseases.

[11]  B. Cheng,et al.  Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population , 2007, Genes and Immunity.

[12]  W. McGuire,et al.  Interleukin-6 (−174C) polymorphism and the risk of sepsis in very low birth weight infants: meta-analysis , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.

[13]  A. Prasad.  Zinc: mechanisms of host defense. , 2007, The Journal of nutrition.

[14]  K. Mehta,et al.  Oral zinc supplementation for reducing mortality in probable neonatal sepsis: A double blind randomized placebo controlled trial , 2013, Indian Pediatrics.

[15]  O. Levy.  Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists , 2005, Journal of endotoxin research.

[16]  Michael G. Barnes,et al.  Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. , 2007, Physiological genomics.

[17]  G. H. McCraken.  Antibiotics in the newborn. , 1975, Canadian Medical Association journal.

[18]  Michael G. Barnes,et al.  Genome-Level Longitudinal Expression of Signaling Pathways and Gene Networks in Pediatric Septic Shock , 2007, Molecular medicine.

[19]  Nana O. Wilson,et al.  CXCL10 Gene Promoter Polymorphism -1447A>G Correlates with Plasma CXCL10 Levels and is Associated with Male Susceptibility to Cerebral Malaria , 2013, PloS one.

[20]  J. Michálek,et al.  Multiple gene-to-gene interactions in children with sepsis: a combination of five gene variants predicts outcome of life-threatening sepsis , 2014, Critical Care.

[21]  J. Friedland,et al.  The paradox of matrix metalloproteinases in infectious disease , 2005, Clinical and experimental immunology.

[22]  R. Tapping,et al.  Human Lipopolysaccharide-binding Protein (LBP) and CD14 Independently Deliver Triacylated Lipoproteins to Toll-like Receptor 1 (TLR1) and TLR2 and Enhance Formation of the Ternary Signaling Complex* , 2013, The Journal of Biological Chemistry.

[23]  L. Golub,et al.  Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. , 2004, Journal of periodontology.

[24]  Robert J Freishtat,et al.  Validating the genomic signature of pediatric septic shock. , 2008, Physiological genomics.

[25]  H. Wong.  Genetics and genomics in pediatric septic shock , 2012, Critical care medicine.

[26]  J. Du,et al.  Association between CD14 Promoter -159C/T Polymorphism and the Risk of Sepsis and Mortality: A Systematic Review and Meta-Analysis , 2013, PloS one.

[27]  C. Cannings,et al.  Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease , 2003, Annals of Internal Medicine.

[28]  H. Whittle,et al.  Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  J. Woessner.  Matrix Metalloproteinase Inhibition: From The Jurassic To The Third Millennium , 1999, Annals of the New York Academy of Sciences.

[30]  B. Zehnbauer,et al.  Association between lymphotoxin-α (tumor necrosis factor-β) intron polymorphism and predisposition to severe sepsis is modified by gender and age , 2010, Critical care medicine.

[31]  A. González-Neira,et al.  Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph , 2010, Haematologica.

[32]  D. Kwiatkowski,et al.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families , 2000, Thorax.

[33]  F. Stüber,et al.  Pilot Study Assessing TNF Gene Polymorphism as a Prognostic Marker for Disease Progression in Neonates with Sepsis , 2000, Infection.

[34]  H. Wong,et al.  Leukocyte subset-derived genomewide expression profiles in pediatric septic shock* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[35]  O. Levy,et al.  Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. , 1999 .

[36]  I. Wortman,et al.  Nasal cytokine production in viral acute upper respiratory infection of childhood. , 1995, The Journal of infectious diseases.

[37]  A. Hoeft,et al.  Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. , 1999, Critical care medicine.

[38]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[39]  A. Randolph,et al.  Genetic polymorphisms in sepsis , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[40]  W. Poole,et al.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. , 2002, Pediatrics.

[41]  J. L. López Sastre,et al.  Neonatal sepsis of nosocomial origin: an epidemiological study from the "Grupo de Hospitales Castrillo" , 2002, Journal of perinatal medicine.

[42]  C. Dinarello,et al.  The role of interleukin-1 in disease. , 1993, The New England journal of medicine.